American pharmaceutical company Eli Lilly plans to build a $3bn manufacturing facility at the Leiden Bio Science Park in ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

Indianapolis-based Eli Lilly and Company announced Monday, Nov. 3 that it plans to build a new $3 billion manufacturing ...

PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...

The hyperlipidemia drugs market is growing due to rising cardiovascular disease prevalence, increasing cholesterol management ...

Eli Lilly, the American pharmaceutical giant, has made two significant announcements that could substantially impact its market position and future growth tr ...

The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...

Aion Medicines, a subsidiary of Exavir Therapeutics, announced the presentation of preclinical data for AM-710, the company's ultra-long-acting small molecule GLP1R agonist, at the ObesityWeek ...

DES MOINES, Iowa, Nov. 4, 2025/PRNewswire/ -- BioSpace, the leader in biopharma news and careers, has published its 2026 Best Places to Work list.

After Pfizer agreed to acquire weight-loss drug developer Metsera for $7.3 billion, Novo Nordisk swooped in with an ...

Weight loss drugs are set to become a disproportionate share of Lilly's business.